Join
Live feed
·
PRReleasevia Quantisnow
Lineage Cell Therapeutics Inc. logo

Lineage Establishes Exclusive Worldwide Collaboration With Genentech for the Development and Commercialization of OpRegen® RPE Cell Therapy for the Treatment of Ocular Disorders

ByQuantisnow·Wall Street's wire, on your screen.
LCTX· Lineage Cell Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LCTX (Lineage Cell Therapeutics Inc.) and more on Quantisnow.